Cingulate

Cingulate EPS Growth

The EPS Growth of Cingulate (CING) as of Nov 11, 2026 is 15.07 %. In the previous year, EPS Growth was 97.99 % — a change of -84.62% (lower).

EPS Growth

15.07 %

YoY

-84.62%

Last updated:

EPS Growth of Cingulate is 2025 15.07 % . EPS Growth of Cingulate was 2024 97.99 % . It decreases by -84.62% lower compared to the previous year.

The Cingulate EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2020
-139.02 USD
Jan 1, 2021
-296.19 USD
Jan 1, 2022
37.28 USD
Jan 1, 2023
-1,815.64 USD
Jan 1, 2024
97.99 USD
Jan 1, 2025
15.07 USD
The Cingulate EPS Growth history
YEAREPS GrowthYoY
15.07 %-84.62%
97.99 %-105.40%
-1,815.64 %-4,970.08%
37.28 %-112.59%
-296.19 %+113.05%
-139.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cingulate Stock analysis

What does Cingulate do? Cingulate Inc is a US-based biopharmaceutical company headquartered in Kansas City, Kansas, that focuses on the development, manufacturing, and commercialization of pharmaceutical products. The firm utilizes its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles designed to improve the lives of patients suffering from commonly diagnosed conditions. The company specifically targets the treatment of attention deficit/hyperactivity disorder (ADHD) through its innovative approach to drug delivery. The firm is currently developing two lead product candidates, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). These drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. By employing this technology, Cingulate Inc aims to provide effective treatment options for ADHD across three core patient segments: children aged 6-12, adolescents aged 13-17, and adults aged 18 and older. Cingulate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cingulate stock

EPS Growth of Cingulate is 15.07 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Cingulate since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Cingulate historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Cingulate

All Key Metrics — Cingulate